Report Description

India ciprofloxacin market is expected to grow at an impressive rate during the forecast period. The India ciprofloxacin market is driven by the growing prevalence of renal disorders, eye infections, among others. Additionally, ciprofloxacin is a second generation fluoroquinolone which is used in the treatment of several ear infections including otitis externa, thereby propelling the market growth through FY2026. Furthermore, growing demand for broad spectrum antibiotic against a wide range of gram positive and negative bacteria’s is expected to fuel the market growth over the next few years.

The India ciprofloxacin market is segmented based on composition, source, form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, otic, intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability.

The major players operating in the India ciprofloxacin market are Cipla Ltd., Aurobindo Pharma Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories Ltd., Wockhardt Limited, Glenmark Pharmaceuticals Ltd., Cadila Healthcare Ltd., Neuland Laboratories Ltd., Aarti Drugs Ltd., Indoco Remedies Ltd and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India ciprofloxacin market from FY2016 to FY2019.
  • To estimate and forecast the market size of India ciprofloxacin market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India ciprofloxacin market based on composition, source, form, route of administration, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India ciprofloxacin market.
  • To identify drivers and challenges for India ciprofloxacin market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India ciprofloxacin market.
  • To identify and analyze the profile of leading players operating in India ciprofloxacin market.
  • To identify key sustainable strategies adopted by market players in India ciprofloxacin market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India ciprofloxacin market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Ciprofloxacin manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to ciprofloxacin

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India ciprofloxacin market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Ciprofloxacin Market, By Composition:
    • Single
    • Combinational
  • India Ciprofloxacin Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Ciprofloxacin Market, By Form:
    • Powder
    • Suspension
    • Capsule
    • Tablet
    • Eye Drops
    • Ear Drop
    • Injection
    • Others
  • India Ciprofloxacin Market, By Route of Administration:
    • Oral
    • Ophthalmic
    • Otic
    • Intravenous
    • Others
  • India Ciprofloxacin Market, By Distribution Channel:
    • Online
    • Offline
  • India Ciprofloxacin Market, By Application:
    • Urinary Tract Infections
    • Lower Respiratory Infections
    • Nosocomial Pneumonia
    • Skin Structure Infections
    • Bone and Joint Infections
    • Intra-abdominal Infections
    • Acute Sinusitis
    • Conjunctivitis
    • Acute Otitis Externa
    • Others
  • India Ciprofloxacin Market, By End User:
    • Adult
    • Pediatric
  • India Ciprofloxacin Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India ciprofloxacin market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Ciprofloxacin market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Ciprofloxacin Market

4.    Executive Summary

5.    Manufacturing Ciprofloxacin

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Ciprofloxacin

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Ciprofloxacin Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Composition (Single v/s Combinational)

7.2.2.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.3.     By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others)

7.2.4.     By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure infections, Bone and Joint infections, Intra-abdominal infections, Acute sinusitis, Conjunctivitis, Acute otitis externa, Others)

7.2.7.     By End User (Adult v/s Paediatric)

7.2.8.     By Region (North, East, South, West)

7.2.9.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Cipla Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Aurobindo Pharma Ltd.

14.1.3.  Sun Pharmaceuticals Industries Ltd.

14.1.4.  Dr. Reddy’s Laboratories Ltd.

14.1.5.  Wockhardt Limited

14.1.6.  Glenmark Pharmaceuticals Ltd.

14.1.7.  Cadila Healthcare Ltd.

14.1.8.  Neuland Laboratories Ltd.

14.1.9.  Aarti Drugs Ltd.

14.1.10.                Indoco Remedies Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions